Chlorhistol

Chlorhistol may be available in the countries listed below.

Ingredient matches for Chlorhistol

Chlorphenamine

Chlorphenamine is reported as an ingredient of Chlorhistol in the following countries:

• Tunisia

International Drug Name Search

Méthadone AP-HP

Méthadone AP-HP may be available in the countries listed below.

Ingredient matches for Méthadone AP-HP

Methadone

Methadone hydrochloride (a derivative of Methadone) is reported as an ingredient of Méthadone AP-HP in the following countries:

• France

International Drug Name Search

Metoclopramide HCl CF

Metoclopramide HCl CF may be available in the countries listed below.

Ingredient matches for Metoclopramide HCl CF

Metoclopramide

Metoclopramide hydrochloride (a derivative of Metoclopramide) is reported as an ingredient of Metoclopramide HCl CF in the following countries:

• Netherlands

International Drug Name Search

Imitrex Statdose

See also: Generic Imitrex

Imitrex Statdose is a brand name of sumatriptan, approved by the FDA in the following formulation(s):

IMITREX STATDOSE (sumatriptan succinate - injectable; subcutaneous)

• 
  Manufacturer: GLAXOSMITHKLINE
  
  Approval date: December 23, 1996
  
  Strength(s): EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) ^[RLD][AB]


• 
  Manufacturer: GLAXOSMITHKLINE
  
  Approval date: February 1, 2006
  
  Strength(s): EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML) ^[RLD]

Has a generic version of Imitrex Statdose been approved?

Yes. The following products are equivalent to Imitrex Statdose:

sumatriptan succinate injectable; subcutaneous

• 
  Manufacturer: SUN PHARM INDS INC
  
  Approval date: June 21, 2011
  
  Strength(s): EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Imitrex Statdose. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Imitrex Statdose.

See also...

• Imitrex Statdose Refill injection Consumer Information (Cerner Multum)
• Imitrex Statdose injection Consumer Information (Cerner Multum)
• Sumatriptan Consumer Information (Wolters Kluwer)
• Sumatriptan Spray Consumer Information (Wolters Kluwer)
• Sumatriptan Tablets Consumer Information (Wolters Kluwer)
• Sumatriptan injection Consumer Information (Cerner Multum)
• Sumatriptan oral/nasal Consumer Information (Cerner Multum)
• Imitrex Stat Dose Refill Advanced Consumer Information (Micromedex)
• Imitrex Stat Dose Refill Subcutaneous Advanced Consumer Information (Micromedex)
• Sumatriptan Advanced Consumer Information (Micromedex)
• Sumatriptan Nasal, Oral, Subcutaneous Advanced Consumer Information (Micromedex)
• Sumatriptan Subcutaneous Advanced Consumer Information (Micromedex)
• Sumatriptan AHFS DI Monographs (ASHP)
• Sumatriptan Succinate AHFS DI Monographs (ASHP)

Calciumacetat-Nefro

Calciumacetat-Nefro may be available in the countries listed below.

Ingredient matches for Calciumacetat-Nefro

Calcium Acetate

Calcium Acetate is reported as an ingredient of Calciumacetat-Nefro in the following countries:

• Germany


• Luxembourg

International Drug Name Search

Alomide Alcon

Alomide Alcon may be available in the countries listed below.

Ingredient matches for Alomide Alcon

Lodoxamide

Lodoxamide tromethamine (a derivative of Lodoxamide) is reported as an ingredient of Alomide Alcon in the following countries:

• Denmark

International Drug Name Search

Depen Titratabs

Pronunciation: PEN-ih-SILL-ah-meen
Generic Name: Penicillamine
Brand Name: Examples include Cuprimine and Depen

Depen Titratabs may cause serious side effects. Patients using Depen Titratabs should remain under the close supervision of their doctor. Tell your doctor immediately if you develop a rash, difficulty breathing or wheezing, chills, fever, sore throat, bruising, or bleeding.

Depen Titratabs is used for:

Treating Wilson disease (excess copper in the body), severe rheumatoid arthritis that has not responded to other treatments, and cystinuria (excess amino acids in the urine, which causes kidney stones). It may also be used for other conditions as determined by your doctor.

Depen Titratabs is a chelating agent. It works by removing excess copper in patients with Wilson disease, reducing excess cystine in patients with cystinuria, and reducing disease activity in patients with rheumatoid arthritis.

Do NOT use Depen Titratabs if:

• you are allergic to any ingredient in Depen Titratabs or to penicillin


• you are pregnant or are breast-feeding


• you have a history of aplastic anemia or agranulocytosis (decreased number of white blood cells) due to penicillamine use


• you have a history of kidney problems (rheumatoid arthritis patients only), blood in the urine, or pemphigus (blistering skin disease)


• you are taking gold therapy (eg, gold salts), antimalarial or cytotoxic medicines (eg, quinine, carboplatin), oxyphenbutazone, or phenylbutazone

Contact your doctor or health care provider right away if any of these apply to you.

Before using Depen Titratabs:

Some medical conditions may interact with Depen Titratabs. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are planning to become pregnant


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you are scheduled for surgery


• if you have Goodpasture syndrome, myasthenia gravis, aplastic anemia, or decreased blood platelets or white blood cells

Some MEDICINES MAY INTERACT with Depen Titratabs. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Antimalarial medicines (eg, atovaquone), cytotoxic medicines (eg, carboplatin, quinine), gold salts, oxyphenbutazone, or phenylbutazone because the risk of side effects, such as kidney problems and blood disorders, may be increased


• Digoxin because its effectiveness may be decreased

This may not be a complete list of all interactions that may occur. Ask your health care provider if Depen Titratabs may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Depen Titratabs:

Use Depen Titratabs as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Take Depen Titratabs on an empty stomach (1 hour before meals or 2 hours after meals).


• Take Depen Titratabs at least 2 hours before or after other medicines containing aluminum or magnesium (antacids), iron, or vitamins that contain iron.


• If you are taking Depen Titratabs for cystinuria, drink plenty of water while taking Depen Titratabs. Drink a pint (16 ounces [480 mL]) at bedtime and another pint during the night, unless directed otherwise by your doctor.


• It may take 1 to 3 months for Depen Titratabs to work.


• If you miss a dose of Depen Titratabs, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Depen Titratabs.

Important safety information:

• Your doctor may prescribe a vitamin B supplement called pyridoxine while you are taking Depen Titratabs. Follow your doctor's instructions for taking this supplement.


• Before you have any medical or dental treatments, emergency care, or surgery, tell the doctor or dentist that you are using Depen Titratabs.


• LAB TESTS, including complete blood cell counts, platelet counts, liver and kidney function tests, urinalysis, and body temperature, may be required to monitor your progress or to check for side effects. Be sure to keep all doctor and lab appointments.


• Use Depen Titratabs with caution in the ELDERLY because they may be more sensitive to its effects.


• Depen Titratabs is not recommended for use in CHILDREN with juvenile rheumatoid arthritis. Safety and effectiveness have not been confirmed.


• PREGNANCY and BREAST-FEEDING: Depen Titratabs has been shown to cause harm to the fetus. If you become, discuss with your doctor the benefits and risks of using Depen Titratabs during pregnancy. It is unknown if Depen Titratabs is excreted in breast milk. Do not breast-feed while taking Depen Titratabs.

Possible side effects of Depen Titratabs:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Diarrhea; loss of appetite; mild stomach pain; nausea; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); black, tarry stools; bleeding or bruising; blood in the urine; burning, itching, peeling, or redness of skin; changes in taste; chills; cough; dark urine; difficult urination; fever; general feeling of discomfort; joint pain; muscle weakness; severe stomach pain; shortness of breath; skin lesions; sore throat; swelling of the feet or legs; vision problems; weight gain; wheezing.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Depen Titratabs side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Depen Titratabs:

Store Depen Titratabs at room temperature, 77 degrees F (25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Depen Titratabs out of the reach of children and away from pets.

General information:

• If you have any questions about Depen Titratabs, please talk with your doctor, pharmacist, or other health care provider.


• Depen Titratabs is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Depen Titratabs. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Depen Titratabs resources

• Depen Titratabs Side Effects (in more detail)
• Depen Titratabs Use in Pregnancy & Breastfeeding
• Depen Titratabs Drug Interactions
• Depen Titratabs Support Group
• 0 Reviews for Depen Titratabs - Add your own review/rating

Compare Depen Titratabs with other medications

• Cystinuria
• Rheumatoid Arthritis
• Wilson's Disease